Neurodiversity Alliance Logo
  • Home
  • Mailing List
  • Contact Us

Oxford Mail: Large rise in ADHD patients prescribed medication

by Anna | Oct 27, 2023 | Uncategorised | 0 comments

Henry Shelford, CEO and Co-Founder of ADHD UK provided comment for the article.

“The NHS should have realised that this was happening and had a plan in place.”

You can read the full article here: https://www.oxfordmail.co.uk/news/23882915.oxfordshire-adhd-patients-increasingly-prescribed-medication/

 

Doctors in England told not to start new patients on ADHD drugs due to shortage

Promoted by Henry Shelford
Neurodiversity Alliance, 49 Greek Street, London. W1D 4EG
© 2024 Neurodiversity Alliance